课题基金 / 基金详情

Therapy induced hypermutation to stimulate immune responses in recurrent cancer

Therapy induced hypermutation to stimulate immune responses in recurrent cancer
治疗诱导超突变以刺激复发性癌症的免疫反应
批准号：
415354
负责人：
White Justin M
金额：
$1.27万
依托单位：
University of British Columbia
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2018
资助国家：
加拿大
项目状态：
已结题
起止时间：
2018-12-01 至 2019-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=415354&lang=en
关键词：
Cancer Chemotherapy Genetics Hypermutation Immune Response P53 Personalized Medicine Sequencing

项目摘要

项目成果

White Justin M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
In the battle against cancer, massive amounts of time and resources have gone towards the development of chemotherapeutic agents that act to kill cancer cells, while leaving healthy cells relatively unaffected. Unfortunately, when these drugs are unable t
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting the translesion synthesis pathway as a potential therapeutic strategy in chemoresistant and late stage cancers
海外基金